LEADER 02703nam  2200601Ia 450 
001 9910144137403321
005 20221206105106.0
010   $a0-470-43856-8
010   $a1-281-73255-9
010   $a9786611732554
010   $a0-470-36871-3
010   $a0-470-36997-3
035   $a(CKB)1000000000537144
035   $a(EBL)353559
035   $a(OCoLC)476175332
035   $a(SSID)ssj0000123014
035   $a(PQKBManifestationID)11141217
035   $a(PQKBTitleCode)TC0000123014
035   $a(PQKBWorkID)10131343
035   $a(PQKB)10661837
035   $a(MiAaPQ)EBC353559
035   $a(MiAaPQ)EBC4025424
035   $a(EXLCZ)991000000000537144
100   $a20080110d2008      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aClassical and adaptive clinical trial designs using ExpDesign Studio [trademark symbol]$b[electronic resource] /$fMark Chang
210   $aHoboken, N.J. $cJohn Wiley$dc2008
215   $a1 online resource (280 p.)
300   $aDescription based upon print version of record.
311   $a0-470-27612-6 
320   $aIncludes bibliographical references and index.
327   $aExpDesign Studio -- Clinical trial design -- Classical trial design -- Group sequential trial design -- Adaptive trial design -- Adaptive trial monitoring -- Oncology adaptive trial design -- Adaptive trial simulator -- Further assistance from ExpDesign Studio.
330   $aExpDesign Studio facilitates more efficient clinical trial design This book introduces pharmaceutical statisticians, scientists, researchers, and others to ExpDesign Studio software for classical and adaptive designs of clinical trials. It includes the Professional Version 5.0 of ExpDesign Studio software that frees pharmaceutical professionals to focus on drug development and related challenges while the software handles the essential calculations and computations. After a hands-on introduction to the software and an overview of clinical trial designs encompassing numerous variations
606   $aDrugs$xTesting$xComputer simulation
606   $aAdaptive sampling (Statistics)
606   $aClinical trials$xData processing
615  0$aDrugs$xTesting$xComputer simulation.
615  0$aAdaptive sampling (Statistics)
615  0$aClinical trials$xData processing.
676   $a615.50724
676   $a615/.190113
700   $aChang$b Mark$0520702
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910144137403321
996   $aClassical and adaptive clinical trial designs using ExpDesign Studio$92139729
997   $aUNINA

LEADER 02084nam  2200589 a 450 
001 9910781608803321
005 20200520144314.0
010   $a1-283-25315-1
010   $a9786613253156
010   $a0-8203-4283-1
035   $a(CKB)2550000000052069
035   $a(OCoLC)759160204
035   $a(CaPaEBR)ebrary10496067
035   $a(SSID)ssj0000649525
035   $a(PQKBManifestationID)11940242
035   $a(PQKBTitleCode)TC0000649525
035   $a(PQKBWorkID)10601556
035   $a(PQKB)11552655
035   $a(MdBmJHUP)muse17862
035   $a(Au-PeEL)EBL3039048
035   $a(CaPaEBR)ebr10496067
035   $a(MiAaPQ)EBC3039048
035   $a(EXLCZ)992550000000052069
100   $a20030731d2004      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 14$aThe Protestant voice in American pluralism$b[electronic resource] /$fMartin E. Marty
210   $aAthens $cUniversity of Georgia Press$dc2004
215   $a1 online resource (97 p.) 
225 1 $aGeorge H. Shriver lecture series in religion in American history ;$vno. 2
300   $aIncludes index.
311   $a0-8203-2580-5 
320   $aIncludes index.
327   $aWhen Protestants ran the show : when homogeneity ruled, 1607 to 1955 -- More rings in the circus : realized pluralism, after 1955 -- Is there still a tent, or are there many tents? : Protestantism gone public, within pluralism.
410  0$aGeorge H. Shriver lecture series in religion in American history ;$vno. 2.
606   $aProtestantism$zUnited States$xHistory
606   $aReligious pluralism$zUnited States$xHistory
607   $aUnited States$xChurch history
615  0$aProtestantism$xHistory.
615  0$aReligious pluralism$xHistory.
676   $a280/.4/0973
700   $aMarty$b Martin E.$f1928-$0700382
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910781608803321
996   $aThe Protestant voice in American pluralism$93832148
997   $aUNINA